<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29668699</article-id><article-id pub-id-type="pmc">5905986</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0195493</article-id><article-id pub-id-type="publisher-id">PONE-D-17-07937</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Heart Rate</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Materials Science</subject><subj-group><subject>Material Properties</subject><subj-group><subject>Mechanical Properties</subject><subj-group><subject>Stiffness</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject><subj-group><subject>Neurological Drug Therapy</subject><subj-group><subject>Anti-Addiction Drug Therapy</subject><subj-group><subject>Nicotine Replacement Therapy</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Behavior</subject><subj-group><subject>Habits</subject><subj-group><subject>Smoking Habits</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Myocardial Infarction</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Cerebrovascular Diseases</subject><subj-group><subject>Stroke</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Stroke</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Analysis of Variance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (Mathematics)</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Analysis of Variance</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Brief exposure to Swedish snus causes divergent vascular responses in healthy male and female volunteers</article-title><alt-title alt-title-type="running-head">Divergent vascular response in males and females to Swedish snus</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5969-8165</contrib-id><name><surname>Antoniewicz</surname><given-names>Lukasz</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Novo</surname><given-names>Mirza</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bosson</surname><given-names>Jenny</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lundb&#x000e4;ck</surname><given-names>Magnus</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Karolinska Institutet, Department of Clinical Sciences, Division of Internal Medicine, Danderyd Hospital, Stockholm, Sweden</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Ume&#x000e5; University, Department of Public Health and Clinical Medicine, Division of Medicine/Respiratory Medicine, Ume&#x000e5;, Sweden</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Stockholm, Sweden</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Kou</surname><given-names>Yu Ru</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>National Yang-Ming University, TAIWAN</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>lukasz.antoniewicz@ki.se</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>4</issue><elocation-id>e0195493</elocation-id><history><date date-type="received"><day>27</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Antoniewicz et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Antoniewicz et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0195493.pdf"/><abstract><sec id="sec001"><title>Introduction</title><p>The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandinavian countries. With declining cigarette sales in the western world, tobacco companies have looked to the development of alternative tobacco products. In 2006 snus products were launched in the US. Even though several studies have demonstrated negative health effects, snus is often depicted as harmless.</p><p>The aim of the present study was to investigate acute vascular effects of snus as measured by arterial stiffness as well as blood pressure and heart rate.</p></sec><sec id="sec002"><title>Methods</title><p>Two separate randomized double-blind crossover studies with the same study design were pooled for analysis. Twenty-nine healthy snus-users (17 females, 12 males) were included. Snus (G&#x000f6;teborgs Rap&#x000e9;) and tobacco free snus (Onico) were administered in a randomized order at two separate visits. Arterial stiffness, blood pressure and heart rate were measured at baseline as well as every five minutes for 40 minutes during exposure. Following snus removal, measurements continued for 30 minutes post exposure. Arterial stiffness was measured using pulse wave velocity (Vicorder) and pulse wave analysis (Sphygmocor).</p></sec><sec id="sec003"><title>Results</title><p>Compared to placebo, snus significantly increased systolic and diastolic blood pressure as well as heart rate, however, only in females (p = 0.004, p = 0.006 and p&#x0003c;0.001 respectively). No changes were seen in arterial stiffness measurements in either gender.</p></sec><sec id="sec004"><title>Conclusion</title><p>We observed an increase in blood pressure and heart rate only in females, but not in males due to snus usage as compared to placebo. This novel finding was surprising and needs to be further investigated considering most of the earlier studies have mainly focused on male snus users and the increasing usage of snus among females.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003793</institution-id><institution>Hj&#x000e4;rt-Lungfonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Lundb&#x000e4;ck</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100007687</institution-id><institution>Svenska L&#x000e4;kares&#x000e4;llskapet</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Lundb&#x000e4;ck</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004348</institution-id><institution>Stockholms L&#x000e4;ns Landsting</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Lundb&#x000e4;ck</surname><given-names>Magnus</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by The Swedish Heart and Lung foundation (ML) <ext-link ext-link-type="uri" xlink:href="https://www.hjart-lung.se/om-oss/about-us-in-english/">https://www.hjart-lung.se/om-oss/about-us-in-english/</ext-link>; the Stockholm City Council and Karolinska Institutet: 20140603 (ML) <ext-link ext-link-type="uri" xlink:href="https://forskningsstod.vmi.se/Ansokan/showSearchSummary.asp?aNr=20140603">https://forskningsstod.vmi.se/Ansokan/showSearchSummary.asp?aNr=20140603</ext-link>; and The Swedish society of Medicine (ML) <ext-link ext-link-type="uri" xlink:href="http://www.sls.se/om-oss/the-swedish-society-of-medicine-in-english/">http://www.sls.se/om-oss/the-swedish-society-of-medicine-in-english/</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="1"/><page-count count="16"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Cigarette smoking is one of the leading causes of premature death and is associated with increased mortality and morbidity due to cardiovascular disease [<xref rid="pone.0195493.ref001" ref-type="bibr">1</xref>]. The WHO estimates that 6 million people die annually due to cigarette smoke exposure [<xref rid="pone.0195493.ref002" ref-type="bibr">2</xref>]. The firmly established association between cigarette smoking and impaired health in combination with increased public awareness has caused cigarette sales to drop dramatically in western nations. Therefore, large transnational tobacco companies have started to look to alternative tobacco products such as Swedish moist snuff, also known as snus [<xref rid="pone.0195493.ref003" ref-type="bibr">3</xref>]. Since 2007 Marlboro, Skoal and Camel have all launched Swedish style snus in the US, which has been aggressively marketed as a potentially healthier alternative to cigarette smoking with advertisement primarily targeting smokers in situations where smoking is prohibited [<xref rid="pone.0195493.ref004" ref-type="bibr">4</xref>].</p><p>Historically, much of the attention from the research community has been focused on the potential adverse effects of snus on the oral mucosa as it is placed between the lip and gums. However, no strong associations between snus usage and oral cancer have been found [<xref rid="pone.0195493.ref005" ref-type="bibr">5</xref>]. Yet, in recent years compelling new evidence of the possible cardiovascular effects of snus has been established. Snus use has been linked to heart failure, development of type 2 diabetes and increased mortality following myocardial infarction and stroke [<xref rid="pone.0195493.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0195493.ref009" ref-type="bibr">9</xref>]. Furthermore, after myocardial infarction, discontinuation of snus use was associated with an almost fifty percent decreased risk in mortality [<xref rid="pone.0195493.ref009" ref-type="bibr">9</xref>]. These findings are not without controversy and several studies present contradicting results regarding the overall risk for cardiovascular disease [<xref rid="pone.0195493.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="pone.0195493.ref013" ref-type="bibr">13</xref>].</p><p>Swedish Match, the largest snus manufacturing tobacco company in Scandinavia and the second largest in the US, has recently submitted an application for snus to be sold as a modified risk tobacco product (MRTP) to the U.S. Food and Drug Administration (FDA) [<xref rid="pone.0195493.ref014" ref-type="bibr">14</xref>]. This would allow the company to market their products as a healthier alternative to smoking as well as allow for removal of certain warning labels. Several studies, sponsored by Swedish Match, dismiss the risk and severity of snus use and try to shift the focus of discussion to snus as a smoking cessation aid [<xref rid="pone.0195493.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0195493.ref019" ref-type="bibr">19</xref>]. However, no clinical studies to date have demonstrated that snus successfully facilitates smoking cessation [<xref rid="pone.0195493.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0195493.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0195493.ref021" ref-type="bibr">21</xref>].</p><p>Furthermore, snus has been linked to increased blood pressure, increased heart rate and endothelial dysfunction, the latter demonstrated by ultrasound assessment of the brachial artery [<xref rid="pone.0195493.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0195493.ref024" ref-type="bibr">24</xref>]. To our knowledge, no placebo-controlled exposure study investigating the acute effects of Swedish snus on arterial stiffness has been performed to date.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Materials and methods</title><sec id="sec007"><title>Study design and subjects</title><p>In two randomized, double blind, crossover studies, healthy young volunteers, who use snus on a daily basis, attended on two occasions at least one week apart (<xref ref-type="fig" rid="pone.0195493.g001">Fig 1</xref>). On the two study days they were exposed to conventional snus (G&#x000f6;teborgs Rap&#x000e9;&#x02122;, nicotine content: 8mg/g) and a flavored, plant fiber-based snus pouch free of tobacco and nicotine (ONICO&#x02122;), which is often used as a snus cessation aid. The volunteers abstained from alcohol for 24 hours and from food, tobacco and caffeine containing drinks for at least 12 hours before both exposures. Following 20 minutes of rest a pouch of snus or non-tobacco/nicotine control was placed under the upper lip of the volunteers. Systolic and diastolic blood pressure (SBP, DBP respectively), heart rate (HR) as well as arterial stiffness, assessed using pulse wave analysis (PWA) and pulse wave velocity (PWV), were measured every five minutes for 45 minutes and during 30 minutes after exposure.</p><fig id="pone.0195493.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.g001</object-id><label>Fig 1</label><caption><title>Study design for study 1 and 2.</title><p>Double blinded crossover study. Blood pressure (BP), heart rate (HR) as well as pulse wave velocity (PWV) and arterial index (AiX75) were measured every 5 minutes in both studies. Additionally, thoracic electrical bioimpedance measurements with stroke volume index (SI), cardiac index (CI) and systemic vascular resistance (SVR) were performed in study 1.</p></caption><graphic xlink:href="pone.0195493.g001"/></fig><p>Two separate studies were performed with the same study design (<xref ref-type="fig" rid="pone.0195493.g001">Fig 1</xref>). Subjects in both studies were recruited in 2010 and 2012 through leaflets on University campus Ume&#x000e5;, advertising in local media and through information on social media. One subject in study 1 participated in only one exposure and was therefore excluded from the study. In the first study six females (mean age &#x000b1; SD: 27.3 &#x000b1; 8.2 years, range: 22 years) were included and thoracic electrical bioimpedance (TEB) was also measured at the same time points. In the second study 23 healthy volunteers (males: n = 12, females n = 11, mean age 30.5 &#x000b1; 5.5 years, range: 19 years) were included.</p><p>The exact same study-design was used in both studies and therefore pooled analysis for HR, BP, PWA and PWV could be performed for study 1 and 2. Because of technical reasons thoracic electrical bioimpedance measurements were only obtained in study 1 and were therefore analyzed separately.</p><p>The study protocols were approved by the local Human Research Ethics Committee at Ume&#x000e5; University, Ume&#x000e5;, Sweden. All subjects have accepted and signed a written informed consent in accordance with the Declaration of Helsinki.</p></sec><sec id="sec008"><title>Arterial stiffness</title><p>Measurement of arterial stiffness was performed in a quiet, temperature controlled room by a blinded operator with all volunteers resting in a semi-supine position. Following 20 minutes of rest, systolic and diastolic blood pressures were measured in duplicate using a semi-automated non-invasive oscillometric sphygmomanometer (Boso-Medicus, Boso, Jungingen, Germany) at baseline and every five minutes during 40 minutes of exposure and 30 minutes post exposure.</p><p>In accordance with manufacturer&#x02019;s instructions, PWA was assessed with micro manometer applanation tonometry (Millar Instruments, Texas, USA) of the right radial artery at the wrist using the SphygmoCor&#x02122; system (AtCor Medical, Sydney, Australia). In brief, via a validated mathematical transfer function, pulse wave analysis obtains an aortic pulse pressure waveform from the radial artery. The arterial pressure waveform constitutes of a forward pressure wave (originated from the ventricular contraction) and a reflected wave caused by the peripheral vascular resistance. From this waveform, augmentation pressure (AP, expressed in mmHg) and augmentation index (AiX), both assessments of central arterial stiffness, are calculated. As AiX is inversely proportional to pulse rate, AiX is normalized for a HR at 75bpm (AiX75). Two independent waveform analyses were obtained from each volunteer. Measurements were accepted according to the SphygmoCor&#x02122; quality control criteria.</p><p>PWV, considered the &#x0201c;gold-standard&#x0201d; measurement of central arterial stiffness, was assessed using a Vicorder&#x02122; system (Skidmore Medical, Bristol, UK). This is a well-validated, non-invasive method of measuring PWV with small inflatable cuffs that are attached around the neck and upper thigh evaluating pulse waves in the carotid and femoral arteries simultaneously. The pulse transit time is assessed and is used along with the distance between the sites to calculate the pulse wave velocity.</p></sec><sec id="sec009"><title>Thoracic electrical bioimpedance</title><p>Hemodynamic measurements were obtained by placing electrodes on the neck and chest of the volunteers using thoracic electrical bioimpedance (Hotman System, Hemo Sapiens Inc., MN, US). This non-invasive equipment was used to determine systemic vascular resistance index (SVRI), cardiac index (CI) and stroke index (SI).</p></sec><sec id="sec010"><title>Statistical analysis</title><p>Statistical calculations were performed using SPSS Statistics (22.0, IBM Corporation, NY, US) and GraphPad Prism (7.0, GraphPad Software Inc., CA, US) software. Data was checked for skewness. Two-way ANOVA for repeated measures was performed for all dependent variables. If Mauchly&#x02019;s test for sphericity was violated, Greenhouse-Geisser or Huynh-Feldt corrected results were presented depending on the highest epsilon value. For comparison of separate time points, paired samples T-test was applied. Independent samples T-test was used to analyze baseline characteristics. P-values of &#x0003c;0.05 were considered to be statistically significant. Blinded investigators performed all analysis.</p></sec></sec><sec sec-type="results" id="sec011"><title>Results</title><p>Pooled analysis of study 1 and 2 was performed for heart rate (HR), systolic and diastolic blood pressure (SBP, DBP), pulse wave analysis (PWA), as well as pulse wave velocity (PWV). A separate analysis for cardiac index (CI), stroke index (SI) and systemic vascular resistance index (SVRI) was performed for study 1. There was no significant difference in baseline characteristics for females between those two studies (<xref ref-type="supplementary-material" rid="pone.0195493.s003">S1 Table</xref>).</p><p>Six women completed study 1 and 23 subjects (12 men and 11 women) completed study 2. The pooled analysis was performed on the two studies combined (n = 29, 12 men and 17 women, mean age: 29.9 &#x000b1; 6.2 years). Study participants used snus for an average of 13.1 years &#x000b1; 6.1 years. Weekly consumption was 5.1 &#x000b1; 1.8 cans of snus. The portion form of snus was used by 89.7% and 10.3% used the loose type.</p><sec id="sec012"><title>Pooled analysis</title><p>Men had significantly higher SBP and PWV and lower AiX75 than women at baseline (<xref ref-type="table" rid="pone.0195493.t001">Table 1</xref>). Women and men used approximately the same amount of snus per week and there was no significant difference in mean age or years of snus usage.</p><table-wrap id="pone.0195493.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.t001</object-id><label>Table 1</label><caption><title>Baseline values for men and women.</title></caption><alternatives><graphic id="pone.0195493.t001g" xlink:href="pone.0195493.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Female (n = 17)</th><th align="center" rowspan="1" colspan="1">Male (n = 12)</th><th align="center" rowspan="1" colspan="1">p-values</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age [years]</td><td align="center" rowspan="1" colspan="1">28.6 &#x000b1; 6.5</td><td align="center" rowspan="1" colspan="1">31.6 &#x000b1; 5.3</td><td align="center" rowspan="1" colspan="1">0.211</td></tr><tr><td align="left" rowspan="1" colspan="1">Snus use [years]</td><td align="center" rowspan="1" colspan="1">11.9 &#x000b1; 5.7</td><td align="center" rowspan="1" colspan="1">14.2 &#x000b1; 6.5</td><td align="center" rowspan="1" colspan="1">0.386</td></tr><tr><td align="left" rowspan="1" colspan="1">Snus [cans/week]</td><td align="center" rowspan="1" colspan="1">5.1 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">5.2 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">0.909</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP [mmHg]</td><td align="center" rowspan="1" colspan="1">108.3 &#x000b1; 8.1</td><td align="center" rowspan="1" colspan="1">119.6 &#x000b1; 9.1</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP [mmHg]</td><td align="center" rowspan="1" colspan="1">66.9 &#x000b1; 6,8</td><td align="center" rowspan="1" colspan="1">70.5 &#x000b1; 7.9</td><td align="center" rowspan="1" colspan="1">0.282</td></tr><tr><td align="left" rowspan="1" colspan="1">HR [bpm]</td><td align="center" rowspan="1" colspan="1">57.0 &#x000b1; 10.1</td><td align="center" rowspan="1" colspan="1">54.0 &#x000b1; 11.6</td><td align="center" rowspan="1" colspan="1">0.108</td></tr><tr><td align="left" rowspan="1" colspan="1">AIx75 [%]</td><td align="center" rowspan="1" colspan="1">0.2 &#x000b1; 10.1</td><td align="center" rowspan="1" colspan="1">-11.0 &#x000b1; 6.1</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PWV [m/s]</td><td align="center" rowspan="1" colspan="1">5.5 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">6.3 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">0.014</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, AiX75 = arterial index for a heart rate at 75bpm, PWV = pulse wave velocity. Expressed as mean values &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap><p>There was no difference in baseline values prior to exposure to snus and placebo-control (<xref ref-type="supplementary-material" rid="pone.0195493.s004">S2 Table</xref>). SBP and DBP increased significantly five minutes following introduction of the snus pouch, when all subjects were analyzed with multiple measures ANOVA (p&#x0003c;0.001, p = 0.003 resp., <xref ref-type="supplementary-material" rid="pone.0195493.s001">S1 Fig</xref>). However, when analyzing women and men separately this increase in SBP and DBP was only significant for women (<xref ref-type="fig" rid="pone.0195493.g002">Fig 2</xref>). Mean changes in SBP and DBP separated for men and women with results from paired samples T-test are presented in <xref ref-type="supplementary-material" rid="pone.0195493.s005">S3 Table</xref>. For women, the mean increase in SBP/DBP during the last 25 minutes of exposure was 7.6 mmHg and 5.7 mmHg and for men 5.9 mmHg and 4.7 mmHg, respectively.</p><fig id="pone.0195493.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.g002</object-id><label>Fig 2</label><caption><title>Mean change in systolic and diastolic blood pressure (SBP, DBP).</title><p>Mean values with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control in males and females. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p></caption><graphic xlink:href="pone.0195493.g002"/></fig><p>HR increased significantly within 5 minutes following introduction of snus in females, and it remained significantly elevated during the whole post exposure period of 30 minutes (<xref ref-type="fig" rid="pone.0195493.g003">Fig 3</xref>). No significant change was seen in males when analyzed with multiple measures ANOVA (<xref ref-type="fig" rid="pone.0195493.g003">Fig 3</xref>). Mean changes in HR and paired samples T-test are shown in <xref ref-type="supplementary-material" rid="pone.0195493.s005">S3 Table</xref>. Mean increase in HR in women during the last 25 minutes of exposure was 11.9 bpm and for men 4.2 bpm.</p><fig id="pone.0195493.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.g003</object-id><label>Fig 3</label><caption><title>Mean change in heart rate (HR).</title><p>Mean values with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control in males and females. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p></caption><graphic xlink:href="pone.0195493.g003"/></fig><p>AiX75 and PWV did not significantly change due to snus exposure as compared to placebo (<xref ref-type="fig" rid="pone.0195493.g004">Fig 4</xref>). There was no difference when analyzing separately for women and men (<xref ref-type="supplementary-material" rid="pone.0195493.s002">S2 Fig</xref>). However, when performing single time point analysis with paired samples T-test, women did show a significant increase during the last 25 minutes of exposure for snus (<xref ref-type="supplementary-material" rid="pone.0195493.s005">S3 Table</xref>). For men we observed a significant increase in AiX75 at the end of exposure and during the post-exposure period for placebo (<xref ref-type="supplementary-material" rid="pone.0195493.s005">S3 Table</xref>).</p><fig id="pone.0195493.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.g004</object-id><label>Fig 4</label><caption><title>Mean change in arterial stiffness.</title><p>Mean values for arterial index adjusted for a heart rate at 75 bpm (AiX75) and pulse wave velocity (PWV) with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p></caption><graphic xlink:href="pone.0195493.g004"/></fig></sec><sec id="sec013"><title>Thoracic electrical bioimpedance results for study 1</title><p>Stroke volume index (SI) significantly decreased 35 minutes following introduction of snus and remained significantly altered 10 minutes into the post exposure period (<xref ref-type="fig" rid="pone.0195493.g005">Fig 5</xref>). SVRI increased 25 minutes after administrating snus, but this was not significant in multiple measures ANOVA. When analyzing with paired samples T-test, this effect was significant at time points 25, 35, 40 and 45min during exposure and during the first 15 minutes into the post exposure period (p-values ranging from 0.012 to 0.044). All other time points showed no statistical significance. Cardiac index (CI) did not significantly change over time in either exposure.</p><fig id="pone.0195493.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195493.g005</object-id><label>Fig 5</label><caption><title>Mean change in cardiac index (CI), stroke volume index (SI) and systemic vascular resistance index (SVRI).</title><p>Mean values with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p></caption><graphic xlink:href="pone.0195493.g005"/></fig></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>Short exposure to one pouch of snus caused an acute increase in systolic and diastolic blood pressure as well as heart rate in female and male volunteers, however to a lesser extent in males. Arterial stiffness measurements did not change following exposure in either gender. In a subgroup of female volunteers, snus caused a decreased stroke index as measured by thoracic electrical bioimpedance. To our knowledge, this is the first study on acute vascular response to Swedish snus assessed using pulse wave velocity, pulse wave analysis and thoracic electrical bioimpedance.</p><p>Interestingly, in the current study females showed a deviating response to snus use than males. Snus exposure caused a significantly higher HR and BP elevation as compared to men, even though weekly snus consumption was generally the same in both men and women. Hering <italic>et al</italic>. have previously shown that smoking one cigarette has similar gender differences, namely a higher HR and SBP in women compared to men [<xref rid="pone.0195493.ref025" ref-type="bibr">25</xref>]. Indeed, there are clear gender differences in cardiovascular risk in smokers, with a fifty per cent increased risk of myocardial infarction for female smokers as compared to male smokers [<xref rid="pone.0195493.ref026" ref-type="bibr">26</xref>].</p><p>Nicotine stimulates the release of catecholamines from adrenal glands and has a direct sympathomimetic effect on the central nervous system and endothelial function [<xref rid="pone.0195493.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0195493.ref028" ref-type="bibr">28</xref>]. In general, women have a lower resting autonomic nerve activity and react more to catecholamines than men [<xref rid="pone.0195493.ref029" ref-type="bibr">29</xref>]. This may suggest that gender responses to nicotine could play an underlying key role in the disparate acute hemodynamic responses demonstrated in the current study.</p><p>The present study was not primarily designed to investigate gender differences and therefore the results were somewhat surprising. Nevertheless, the observed discrepancy in acute responses to Swedish snus between men and women is highly interesting, as most of the previous cohort studies for the cardiovascular risk of snus use have been solely performed in male subjects [<xref rid="pone.0195493.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0195493.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0195493.ref013" ref-type="bibr">13</xref>]. This may be attributed to the fact that the prevalence of snus use is still lower in women as compared to men, as four percent of Swedish women use snus on a daily basis and 5.8 percent of American women report having ever tried snus [<xref rid="pone.0195493.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0195493.ref031" ref-type="bibr">31</xref>]. However, in the countries where snus is available, there has been a steady increase among female snus users [<xref rid="pone.0195493.ref032" ref-type="bibr">32</xref>]. More extensive data exists for cigarette use and it has been shown that smoking females have a higher relative risk for myocardial infarction than smoking males [<xref rid="pone.0195493.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0195493.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0195493.ref034" ref-type="bibr">34</xref>]. It is important to address this gender difference in future studies to properly assess cardiovascular risk for female snus users.</p><p>Usage of a snus pouch in the current study gave immediate effects on HR and BP, which is in line with previous findings (Rohani, Agewall 2004). Similar effects have also been demonstrated following smoking of one cigarette [<xref rid="pone.0195493.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0195493.ref036" ref-type="bibr">36</xref>]. This increase in HR and BP may be attributed to the nicotine content in these tobacco products. Benowitz <italic>et al</italic>. demonstrated that nicotine infusion caused a sudden increase in BP and HR [<xref rid="pone.0195493.ref037" ref-type="bibr">37</xref>]. This theory is further supported by Adamopoulos <italic>et al</italic>. who showed that administration of one tablet of nicotine (2mg) caused similar effects [<xref rid="pone.0195493.ref038" ref-type="bibr">38</xref>]. As mentioned before, nicotine has a direct sympathomimetic effect, which subsequently causes a release of catecholamines [<xref rid="pone.0195493.ref027" ref-type="bibr">27</xref>]. These catecholamines, specifically epinephrine and norepinephrine, are pro-arrhythmogenic and may also have a pro-thrombotic effect [<xref rid="pone.0195493.ref039" ref-type="bibr">39</xref>&#x02013;<xref rid="pone.0195493.ref042" ref-type="bibr">42</xref>]. Taken together, the high and prolonged nicotine exposure in snus users may explain the higher incidence of fatal stroke and fatal myocardial infarctions in habitual snus users [<xref rid="pone.0195493.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0195493.ref013" ref-type="bibr">13</xref>]. It may also account for that discontinuation of snus following myocardial infarction reduces mortality by almost fifty per cent [<xref rid="pone.0195493.ref009" ref-type="bibr">9</xref>]. On the other hand, nicotine replacement therapy (NRT) does seem to be safe following myocardial infarction and it has not been shown to increase the risk for cardiovascular disease during a follow-up period of 12 months [<xref rid="pone.0195493.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0195493.ref044" ref-type="bibr">44</xref>]. One possible explanation may be that Swedish snus generally has a pH in the range of 7.8&#x02013;8.5 (compared to an average pH of 5.3 in cigarette smoke) [<xref rid="pone.0195493.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0195493.ref046" ref-type="bibr">46</xref>]. Increasing the pH increases the portion of free base (unprotonated) form of nicotine, which accelerates mucosal nicotine absorption. Therefore snus users tend to have higher and more prolonged nicotine absorption than NRT users due to the high pH in snus [<xref rid="pone.0195493.ref047" ref-type="bibr">47</xref>].</p><p>In addition to nicotine, there are several other components found in snus that may cause the demonstrated effect, including polycyclic aromatic hydrocarbons (PAHs) or aldehydes [<xref rid="pone.0195493.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0195493.ref049" ref-type="bibr">49</xref>]. PAHs are organic chemicals, many of which are classified as carcinogens, which cause damage in the lung tissue when inhaled. However, PAHs can also be ingested or absorbed following dermal and mucosal exposure [<xref rid="pone.0195493.ref050" ref-type="bibr">50</xref>]. It has been suggested that PAHs may affect the redox balance in favor of reactive oxygen species (ROS). ROS cause oxidative damage to biological structures leading to various diseases including cancer, atherosclerosis and cardiovascular disease [<xref rid="pone.0195493.ref051" ref-type="bibr">51</xref>].</p><p>In the present study we assessed the acute effects on aortic stiffness and distensibility measured by pulse wave analysis and pulse wave velocity. However, we did not observe any acute changes in AiX75 or PWV. In a similar study, but without placebo-control, AiX75 was shown to increase following exposure to American smokeless tobacco (ASLT) in a group of habitual users [<xref rid="pone.0195493.ref052" ref-type="bibr">52</xref>]. ASLT differs from Swedish snus with higher levels of carcinogens like PAHs and aldehydes due to fire curing during manufacturing [<xref rid="pone.0195493.ref049" ref-type="bibr">49</xref>]. Similar effects with acute increase in arterial stiffness were observed following smoking of one cigarette or administering of one 2mg nicotine tablet [<xref rid="pone.0195493.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0195493.ref038" ref-type="bibr">38</xref>]. In the present study, we investigated daily snus users following a snus-free period of twelve hours. It may be possible that arterial stiffness is chronically altered in snus users due to differences in nicotine delivery compared to smokers or users of nicotine gum. Snus users tend to have very long exposure times for around 10 hours per day resulting in prolonged high nicotine-levels [<xref rid="pone.0195493.ref047" ref-type="bibr">47</xref>, <xref rid="pone.0195493.ref053" ref-type="bibr">53</xref>]. Chronic exposure slows down nicotine metabolism as compared to what is seen following occasional exposure [<xref rid="pone.0195493.ref054" ref-type="bibr">54</xref>]. Therefore the prolonged nicotine exposure often seen in snus users may attenuate certain acute effects of nicotine [<xref rid="pone.0195493.ref055" ref-type="bibr">55</xref>].</p><p>As demonstrated in the current study, short-term exposure to snus has an immediate impact on cardiac function and systemic vascular resistance measured using thoracic electrical bioimpedance. This non-invasive method is mostly used to quickly assess cardiac function in a critical care setting, yet is also used in outpatient care settings [<xref rid="pone.0195493.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0195493.ref057" ref-type="bibr">57</xref>]. We observed a sudden decrease in SI and a trend towards increased SVRI following 20 min of snus exposure. This observation was seen at a later time-point than the effects on HR and BP. Sundstr&#x000f6;m <italic>et al</italic>. have previously shown that acute exposure to Swedish snus caused a decrease in diastolic function as assessed by cardioechography [<xref rid="pone.0195493.ref058" ref-type="bibr">58</xref>]. Similar effects on cardiac function were also found following smoking of one cigarette [<xref rid="pone.0195493.ref059" ref-type="bibr">59</xref>]. As discussed before, it is possible that nicotine exerts these acute effects on cardiac function, but other compounds may play a crucial role.</p><p>Even though we did not observe any acute effects on arterial stiffness, we found that women had overall higher AiX75, but slightly lower PWV than men. Similar gender differences have been previously reported in healthy volunteers [<xref rid="pone.0195493.ref060" ref-type="bibr">60</xref>&#x02013;<xref rid="pone.0195493.ref062" ref-type="bibr">62</xref>]. Physiological differences between men and women, like hormonal or constitutional ones have been discussed as possible explanations for this phenomenon [<xref rid="pone.0195493.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0195493.ref064" ref-type="bibr">64</xref>]. On the other hand, some studies suggest a higher cardiovascular risk for women with elevated arterial index compared to men [<xref rid="pone.0195493.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0195493.ref066" ref-type="bibr">66</xref>]. Our study participants were habitual snus-users and we observed no differences in snus consumption between males and females. Accordingly, differences in snus consumption cannot explain this finding. The fact that women had overall higher arterial stiffness and a higher acute hemodynamic response to acute snus exposure suggests strongly that the cardiovascular risk for snus using women needs to be further elucidated.</p><sec id="sec015"><title>Limitations</title><p>This study was not designed to investigate gender differences. Therefore results have to be interpreted with caution.</p><p>Data from two studies was pooled for analysis. Even though we had identical study designs, two separate investigators performed arterial stiffness measurements.</p><p>Thoracic electrical bioimpedance measurements were only performed in the six female subjects in study 1. A study involving more study participants including male volunteers would strengthen our thoracic electrical bioimpedance results.</p></sec></sec><sec sec-type="conclusions" id="sec016"><title>Conclusions</title><p>Brief exposure to Swedish snus causes acute changes in blood pressure and heart rate, however this change is more pronounced in females. The novel finding that snus may have different gender related vascular effects needs to be further investigated, especially as prior health effect studies have mostly focused on males.</p></sec><sec sec-type="supplementary-material" id="sec017"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0195493.s001"><label>S1 Fig</label><caption><title>Mean change in systolic and diastolic blood pressure (SBP, DBP).</title><p>Mean values with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p><p>(TIFF)</p></caption><media xlink:href="pone.0195493.s001.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s002"><label>S2 Fig</label><caption><title>Mean change in arterial stiffness.</title><p>Mean values for arterial index adjusted for a heart rate at 75 bpm (AiX75) and pulse wave velocity (PWV) with standard deviations during 45 minutes of exposure and 30 minutes post exposure to snus or control, separated for males and females. P-values are presented for the interaction of time and exposure in multiple measures ANOVA.</p><p>(TIFF)</p></caption><media xlink:href="pone.0195493.s002.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s003"><label>S1 Table</label><caption><title>Baseline characteristics for females in study 1 and 2.</title><p>SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, AiX75 = arterial index for a heart rate at 75bpm, PWV = pulse wave velocity. Expressed as mean values &#x000b1; SD.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195493.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s004"><label>S2 Table</label><caption><title>Baseline values prior to exposure.</title><p>SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, AiX75 = arterial index for a heart rate at 75bpm, PWV = pulse wave velocity. Expressed as mean values &#x000b1; SD.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195493.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s005"><label>S3 Table</label><caption><title>Mean values &#x000b1; SD, (mean changes &#x000b1; SD from baseline) separated by gender.</title><p>SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, AiX75 = arterial index for a heart rate at 75bpm, PWV = pulse wave velocity. Early exposure = 0&#x02013;20 minutes of exposure, late exposure = 20&#x02013;45 minutes of exposure, post exposure = 0&#x02013;30 minutes post exposure. P-values for mean change from baseline: *&#x0003c;0.001, &#x02020;&#x0003c;0.01, &#x02020;&#x02020;&#x0003c;0.05.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195493.s005.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s006"><label>S1 Dataset</label><caption><title>SPSS dataset: Snus study 1.</title><p>(SAV)</p></caption><media xlink:href="pone.0195493.s006.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195493.s007"><label>S2 Dataset</label><caption><title>SPSS dataset: Pooled analysis.</title><p>(SAV)</p></caption><media xlink:href="pone.0195493.s007.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors would like to thank research nurses Annika Johansson and Frida Holmstr&#x000f6;m at the Respiratory Medicine Research Facility, Ume&#x000e5; University Hospital, for their technical assistance. We would like to thank lab engineers Dr. Gregory Rankin and Dr. Jamshid Pourazar for cotinine analysis. We would like to thank Dr. Alexis Milton for performing the measurements in study 1.</p></ack><ref-list><title>References</title><ref id="pone.0195493.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name>., <name><surname>Adachi</surname><given-names>H</given-names></name>, <name><surname>Mulder</surname><given-names>I</given-names></name>, <name><surname>Kromhout</surname><given-names>D</given-names></name>, <name><surname>Menotti</surname><given-names>A</given-names></name>, <name><surname>Nissinen</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study</article-title>. <source>Archives of internal medicine</source>. <year>1999</year>;<volume>159</volume>(<issue>7</issue>):<fpage>733</fpage>&#x02013;<lpage>40</lpage>. Epub 1999/04/28. .<pub-id pub-id-type="pmid">10218754</pub-id></mixed-citation></ref><ref id="pone.0195493.ref002"><label>2</label><mixed-citation publication-type="other">WHO. WHO Report on the Global Tobacco Epidemic. 2013.</mixed-citation></ref><ref id="pone.0195493.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Peeters</surname><given-names>S</given-names></name>, <name><surname>Gilmore</surname><given-names>AB</given-names></name>. <article-title>Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials</article-title>. <source>PLoS medicine</source>. <year>2013</year>;<volume>10</volume>(<issue>9</issue>):<fpage>e1001506</fpage> Epub 2013/09/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1001506">10.1371/journal.pmed.1001506</ext-link></comment> ; PubMed Central PMCID: PMCPMC3769209.<pub-id pub-id-type="pmid">24058299</pub-id></mixed-citation></ref><ref id="pone.0195493.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Delnevo</surname><given-names>CD</given-names></name>, <name><surname>Wackowski</surname><given-names>OA</given-names></name>, <name><surname>Giovenco</surname><given-names>DP</given-names></name>, <name><surname>Manderski</surname><given-names>MT</given-names></name>, <name><surname>Hrywna</surname><given-names>M</given-names></name>, <name><surname>Ling</surname><given-names>PM</given-names></name>. <article-title>Examining market trends in the United States smokeless tobacco use: 2005&#x02013;2011</article-title>. <source>Tob Control</source>. <year>2012</year> Epub 2012/11/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/tobaccocontrol-2012-050739">10.1136/tobaccocontrol-2012-050739</ext-link></comment> ; PubMed Central PMCID: PMC3604094.<pub-id pub-id-type="pmid">23117999</pub-id></mixed-citation></ref><ref id="pone.0195493.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>G</given-names></name>, <name><surname>Bjornberg</surname><given-names>G</given-names></name>, <name><surname>Curvall</surname><given-names>M</given-names></name>. <article-title>Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study</article-title>. <source>Journal of oral pathology &#x00026; medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology</source>. <year>1994</year>;<volume>23</volume>(<issue>4</issue>):<fpage>161</fpage>&#x02013;<lpage>7</lpage>. Epub 1994/04/01. .<pub-id pub-id-type="pmid">8046653</pub-id></mixed-citation></ref><ref id="pone.0195493.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Boffetta</surname><given-names>P</given-names></name>, <name><surname>Straif</surname><given-names>K</given-names></name>. <article-title>Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis</article-title>. <source>Bmj</source>. <year>2009</year>;<volume>339</volume>:<fpage>b3060</fpage> Epub 2009/08/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.b3060">10.1136/bmj.b3060</ext-link></comment> ; PubMed Central PMCID: PMCPMC2728803.<pub-id pub-id-type="pmid">19690343</pub-id></mixed-citation></ref><ref id="pone.0195493.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Ostenson</surname><given-names>CG</given-names></name>, <name><surname>Hilding</surname><given-names>A</given-names></name>, <name><surname>Grill</surname><given-names>V</given-names></name>, <name><surname>Efendic</surname><given-names>S</given-names></name>. <article-title>High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men</article-title>. <source>Scand J Public Health</source>. <year>2012</year>;<volume>40</volume>(<issue>8</issue>):<fpage>730</fpage>&#x02013;<lpage>7</lpage>. Epub 2012/11/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1403494812459814">10.1177/1403494812459814</ext-link></comment> .<pub-id pub-id-type="pmid">23117209</pub-id></mixed-citation></ref><ref id="pone.0195493.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Arefalk</surname><given-names>G</given-names></name>, <name><surname>Hergens</surname><given-names>MP</given-names></name>, <name><surname>Ingelsson</surname><given-names>E</given-names></name>, <name><surname>Arnlov</surname><given-names>J</given-names></name>, <name><surname>Michaelsson</surname><given-names>K</given-names></name>, <name><surname>Lind</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts</article-title>. <source>Eur J Prev Cardiol</source>. <year>2012</year>;<volume>19</volume>(<issue>5</issue>):<fpage>1120</fpage>&#x02013;<lpage>7</lpage>. Epub 2011/08/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1741826711420003">10.1177/1741826711420003</ext-link></comment> .<pub-id pub-id-type="pmid">21828223</pub-id></mixed-citation></ref><ref id="pone.0195493.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Arefalk</surname><given-names>G</given-names></name>, <name><surname>Hambraeus</surname><given-names>K</given-names></name>, <name><surname>Lind</surname><given-names>L</given-names></name>, <name><surname>Michaelsson</surname><given-names>K</given-names></name>, <name><surname>Lindahl</surname><given-names>B</given-names></name>, <name><surname>Sundstrom</surname><given-names>J</given-names></name>. <article-title>Discontinuation of smokeless tobacco and mortality risk after myocardial infarction</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>130</volume>(<issue>4</issue>):<fpage>325</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.113.007252">10.1161/CIRCULATIONAHA.113.007252</ext-link></comment> .<pub-id pub-id-type="pmid">24958793</pub-id></mixed-citation></ref><ref id="pone.0195493.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>J</given-names></name>, <name><surname>Galanti</surname><given-names>MR</given-names></name>, <name><surname>Hergens</surname><given-names>MP</given-names></name>, <name><surname>Fredlund</surname><given-names>P</given-names></name>, <name><surname>Ahlbom</surname><given-names>A</given-names></name>, <name><surname>Alfredsson</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies</article-title>. <source>Eur J Epidemiol</source>. <year>2012</year>;<volume>27</volume>(<issue>10</issue>):<fpage>771</fpage>&#x02013;<lpage>9</lpage>. Epub 2012/06/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10654-012-9704-8">10.1007/s10654-012-9704-8</ext-link></comment> .<pub-id pub-id-type="pmid">22722951</pub-id></mixed-citation></ref><ref id="pone.0195493.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>J</given-names></name>, <name><surname>Pedersen</surname><given-names>NL</given-names></name>, <name><surname>Galanti</surname><given-names>MR</given-names></name>, <name><surname>Andersson</surname><given-names>T</given-names></name>, <name><surname>Ahlbom</surname><given-names>A</given-names></name>, <name><surname>Hallqvist</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry</article-title>. <source>J Intern Med</source>. <year>2009</year>;<volume>265</volume>(<issue>6</issue>):<fpage>717</fpage>&#x02013;<lpage>24</lpage>. Epub 2009/06/09. .<pub-id pub-id-type="pmid">19504754</pub-id></mixed-citation></ref><ref id="pone.0195493.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Johansson</surname><given-names>SE</given-names></name>, <name><surname>Sundquist</surname><given-names>K</given-names></name>, <name><surname>Qvist</surname><given-names>J</given-names></name>, <name><surname>Sundquist</surname><given-names>J</given-names></name>. <article-title>Smokeless tobacco and coronary heart disease: a 12-year follow-up study</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source>. <year>2005</year>;<volume>12</volume>(<issue>4</issue>):<fpage>387</fpage>&#x02013;<lpage>92</lpage>. Epub 2005/08/05. doi: 00149831-200508000-00013 [pii]. .<pub-id pub-id-type="pmid">16079648</pub-id></mixed-citation></ref><ref id="pone.0195493.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>J</given-names></name>, <name><surname>Galanti</surname><given-names>MR</given-names></name>, <name><surname>Hergens</surname><given-names>MP</given-names></name>, <name><surname>Fredlund</surname><given-names>P</given-names></name>, <name><surname>Ahlbom</surname><given-names>A</given-names></name>, <name><surname>Alfredsson</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival</article-title>. <source>J Intern Med</source>. <year>2014</year>;<volume>276</volume>(<issue>1</issue>):<fpage>87</fpage>&#x02013;<lpage>95</lpage>. Epub 2014/02/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/joim.12219">10.1111/joim.12219</ext-link></comment> .<pub-id pub-id-type="pmid">24548296</pub-id></mixed-citation></ref><ref id="pone.0195493.ref014"><label>14</label><mixed-citation publication-type="other">F.D.A. Swedish Match North America MRTP Applications 2014 [05/01/2015]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.accessdata.fda.gov/Static/widgets/tobacco/SMNA_MRTPA_FDA-2014-N-1051.html">http://www.accessdata.fda.gov/Static/widgets/tobacco/SMNA_MRTPA_FDA-2014-N-1051.html</ext-link>.</mixed-citation></ref><ref id="pone.0195493.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Joksic</surname><given-names>G</given-names></name>, <name><surname>Spasojevic-Tisma</surname><given-names>V</given-names></name>, <name><surname>Antic</surname><given-names>R</given-names></name>, <name><surname>Nilsson</surname><given-names>R</given-names></name>, <name><surname>Rutqvist</surname><given-names>LE</given-names></name>. <article-title>Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation</article-title>. <source>Harm Reduct J</source>. <year>2011</year>;<volume>8</volume>(<issue>1</issue>):<fpage>25</fpage> Epub 2011/09/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1477-7517-8-25">10.1186/1477-7517-8-25</ext-link></comment> ; PubMed Central PMCID: PMCPMC3186733.<pub-id pub-id-type="pmid">21914165</pub-id></mixed-citation></ref><ref id="pone.0195493.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Rutqvist</surname><given-names>LE</given-names></name>. <article-title>Population-based survey of cessation aids used by Swedish smokers</article-title>. <source>Harm Reduct J</source>. <year>2012</year>;<volume>9</volume>:<fpage>38</fpage> Epub 2012/12/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1477-7517-9-38">10.1186/1477-7517-9-38</ext-link></comment> ; PubMed Central PMCID: PMCPMC3539856.<pub-id pub-id-type="pmid">23206988</pub-id></mixed-citation></ref><ref id="pone.0195493.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>PN</given-names></name>. <article-title>The effect on health of switching from cigarettes to snus&#x02014;a review</article-title>. <source>Regul Toxicol Pharmacol</source>. <year>2013</year>;<volume>66</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>5</lpage>. Epub 2013/03/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yrtph.2013.02.010">10.1016/j.yrtph.2013.02.010</ext-link></comment> .<pub-id pub-id-type="pmid">23454227</pub-id></mixed-citation></ref><ref id="pone.0195493.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>PN</given-names></name>. <article-title>Epidemiological evidence relating snus to health&#x02014;an updated review based on recent publications</article-title>. <source>Harm Reduct J</source>. <year>2013</year>;<volume>10</volume>:<fpage>36</fpage> Epub 2013/12/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1477-7517-10-36">10.1186/1477-7517-10-36</ext-link></comment> ; PubMed Central PMCID: PMCPMC4029226.<pub-id pub-id-type="pmid">24314326</pub-id></mixed-citation></ref><ref id="pone.0195493.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>PN</given-names></name>. <article-title>Health risks related to dual use of cigarettes and snus&#x02014;a systematic review</article-title>. <source>Regul Toxicol Pharmacol</source>. <year>2014</year>;<volume>69</volume>(<issue>1</issue>):<fpage>125</fpage>&#x02013;<lpage>34</lpage>. Epub 2013/11/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.yrtph.2013.10.007">10.1016/j.yrtph.2013.10.007</ext-link></comment> .<pub-id pub-id-type="pmid">24184647</pub-id></mixed-citation></ref><ref id="pone.0195493.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Popova</surname><given-names>L</given-names></name>, <name><surname>Ling</surname><given-names>PM</given-names></name>. <article-title>Alternative tobacco product use and smoking cessation: a national study</article-title>. <source>Am J Public Health</source>. <year>2013</year>;<volume>103</volume>(<issue>5</issue>):<fpage>923</fpage>&#x02013;<lpage>30</lpage>. Epub 2013/03/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2105/AJPH.2012.301070">10.2105/AJPH.2012.301070</ext-link></comment> ; PubMed Central PMCID: PMCPMC3661190.<pub-id pub-id-type="pmid">23488521</pub-id></mixed-citation></ref><ref id="pone.0195493.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Gilljam</surname><given-names>H</given-names></name>, <name><surname>Galanti</surname><given-names>MR</given-names></name>. <article-title>Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden</article-title>. <source>Addiction</source>. <year>2003</year>;<volume>98</volume>(<issue>9</issue>):<fpage>1183</fpage>&#x02013;<lpage>9</lpage>. Epub 2003/08/22. .<pub-id pub-id-type="pmid">12930201</pub-id></mixed-citation></ref><ref id="pone.0195493.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Bolinder</surname><given-names>G</given-names></name>, <name><surname>de Faire</surname><given-names>U</given-names></name>. <article-title>Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users</article-title>. <source>Am J Hypertens</source>. <year>1998</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1153</fpage>&#x02013;<lpage>63</lpage>. Epub 1998/11/03. doi: S0895-7061(98)00137-X [pii]. .<pub-id pub-id-type="pmid">9799031</pub-id></mixed-citation></ref><ref id="pone.0195493.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Bolinder</surname><given-names>G</given-names></name>, <name><surname>Alfredsson</surname><given-names>L</given-names></name>, <name><surname>Englund</surname><given-names>A</given-names></name>, <name><surname>de Faire</surname><given-names>U</given-names></name>. <article-title>Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers</article-title>. <source>Am J Public Health</source>. <year>1994</year>;<volume>84</volume>(<issue>3</issue>):<fpage>399</fpage>&#x02013;<lpage>404</lpage>. Epub 1994/03/01. PubMed Central PMCID: PMCPmc1614817. <pub-id pub-id-type="pmid">8129055</pub-id></mixed-citation></ref><ref id="pone.0195493.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Rohani</surname><given-names>M</given-names></name>, <name><surname>Agewall</surname><given-names>S</given-names></name>. <article-title>Oral snuff impairs endothelial function in healthy snuff users</article-title>. <source>J Intern Med</source>. <year>2004</year>;<volume>255</volume>(<issue>3</issue>):<fpage>379</fpage>&#x02013;<lpage>83</lpage>. Epub 2004/02/12. doi: 1279 [pii]. .<pub-id pub-id-type="pmid">14871462</pub-id></mixed-citation></ref><ref id="pone.0195493.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Hering</surname><given-names>D</given-names></name>, <name><surname>Somers</surname><given-names>VK</given-names></name>, <name><surname>Kara</surname><given-names>T</given-names></name>, <name><surname>Jazdzewski</surname><given-names>K</given-names></name>, <name><surname>Jurak</surname><given-names>P</given-names></name>, <name><surname>Kucharska</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Heightened acute circulatory responses to smoking in women</article-title>. <source>Blood Press</source>. <year>2008</year>;<volume>17</volume>(<issue>3</issue>):<fpage>141</fpage>&#x02013;<lpage>6</lpage>. Epub 2008/07/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/08037050802185780">10.1080/08037050802185780</ext-link></comment> .<pub-id pub-id-type="pmid">18608198</pub-id></mixed-citation></ref><ref id="pone.0195493.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Prescott</surname><given-names>E</given-names></name>, <name><surname>Hippe</surname><given-names>M</given-names></name>, <name><surname>Schnohr</surname><given-names>P</given-names></name>, <name><surname>Hein</surname><given-names>HO</given-names></name>, <name><surname>Vestbo</surname><given-names>J</given-names></name>. <article-title>Smoking and risk of myocardial infarction in women and men: longitudinal population study</article-title>. <source>Bmj</source>. <year>1998</year>;<volume>316</volume>(<issue>7137</issue>):<fpage>1043</fpage>&#x02013;<lpage>7</lpage>. Epub 1998/04/29. ; PubMed Central PMCID: PMCPMC28505.<pub-id pub-id-type="pmid">9552903</pub-id></mixed-citation></ref><ref id="pone.0195493.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Adamopoulos</surname><given-names>D</given-names></name>, <name><surname>van de Borne</surname><given-names>P</given-names></name>, <name><surname>Argacha</surname><given-names>JF</given-names></name>. <article-title>New insights into the sympathetic, endothelial and coronary effects of nicotine</article-title>. <source>Clinical and experimental pharmacology &#x00026; physiology</source>. <year>2008</year>;<volume>35</volume>(<issue>4</issue>):<fpage>458</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-1681.2008.04896.x">10.1111/j.1440-1681.2008.04896.x</ext-link></comment> .<pub-id pub-id-type="pmid">18307741</pub-id></mixed-citation></ref><ref id="pone.0195493.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Leone</surname><given-names>A</given-names></name>. <article-title>Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage</article-title>. <source>Current pharmaceutical design</source>. <year>2015</year>;<volume>21</volume>(<issue>30</issue>):<fpage>4370</fpage>&#x02013;<lpage>9</lpage>. Epub 2015/08/04. .<pub-id pub-id-type="pmid">26234797</pub-id></mixed-citation></ref><ref id="pone.0195493.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Christou</surname><given-names>DD</given-names></name>, <name><surname>Jones</surname><given-names>PP</given-names></name>, <name><surname>Jordan</surname><given-names>J</given-names></name>, <name><surname>Diedrich</surname><given-names>A</given-names></name>, <name><surname>Robertson</surname><given-names>D</given-names></name>, <name><surname>Seals</surname><given-names>DR</given-names></name>. <article-title>Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>111</volume>(<issue>4</issue>):<fpage>494</fpage>&#x02013;<lpage>8</lpage>. Epub 2005/02/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.0000153864.24034.A6">10.1161/01.CIR.0000153864.24034.A6</ext-link></comment> .<pub-id pub-id-type="pmid">15687139</pub-id></mixed-citation></ref><ref id="pone.0195493.ref030"><label>30</label><mixed-citation publication-type="other">SCB. Statistics Sweden 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.statistikdatabasen.scb.se/">http://www.statistikdatabasen.scb.se/</ext-link>.</mixed-citation></ref><ref id="pone.0195493.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>SH</given-names></name>, <name><surname>Gamst</surname><given-names>A</given-names></name>, <name><surname>Lee</surname><given-names>M</given-names></name>, <name><surname>Cummins</surname><given-names>S</given-names></name>, <name><surname>Yin</surname><given-names>L</given-names></name>, <name><surname>Zoref</surname><given-names>L</given-names></name>. <article-title>The use and perception of electronic cigarettes and snus among the U.S. population</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e79332</fpage> Epub 2013/11/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0079332">10.1371/journal.pone.0079332</ext-link></comment> ; PubMed Central PMCID: PMCPMC3824062.<pub-id pub-id-type="pmid">24250756</pub-id></mixed-citation></ref><ref id="pone.0195493.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Stegmayr</surname><given-names>B</given-names></name>, <name><surname>Eliasson</surname><given-names>M</given-names></name>, <name><surname>Rodu</surname><given-names>B</given-names></name>. <article-title>The decline of smoking in northern Sweden</article-title>. <source>Scand J Public Health</source>. <year>2005</year>;<volume>33</volume>(<issue>4</issue>):<fpage>321</fpage>&#x02013;<lpage>4</lpage>; discussion 243. Epub 2005/08/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14034940510032301">10.1080/14034940510032301</ext-link></comment> .<pub-id pub-id-type="pmid">16087495</pub-id></mixed-citation></ref><ref id="pone.0195493.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Njolstad</surname><given-names>I</given-names></name>, <name><surname>Arnesen</surname><given-names>E</given-names></name>, <name><surname>Lund-Larsen</surname><given-names>PG</given-names></name>. <article-title>Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study</article-title>. <source>Circulation</source>. <year>1996</year>;<volume>93</volume>(<issue>3</issue>):<fpage>450</fpage>&#x02013;<lpage>6</lpage>. Epub 1996/02/01. .<pub-id pub-id-type="pmid">8565161</pub-id></mixed-citation></ref><ref id="pone.0195493.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Tverdal</surname><given-names>A</given-names></name>, <name><surname>Thelle</surname><given-names>D</given-names></name>, <name><surname>Stensvold</surname><given-names>I</given-names></name>, <name><surname>Leren</surname><given-names>P</given-names></name>, <name><surname>Bjartveit</surname><given-names>K</given-names></name>. <article-title>Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35&#x02013;49 years</article-title>. <source>Journal of clinical epidemiology</source>. <year>1993</year>;<volume>46</volume>(<issue>5</issue>):<fpage>475</fpage>&#x02013;<lpage>87</lpage>. .<pub-id pub-id-type="pmid">8501474</pub-id></mixed-citation></ref><ref id="pone.0195493.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Mahmud</surname><given-names>A</given-names></name>, <name><surname>Feely</surname><given-names>J</given-names></name>. <article-title>Effect of smoking on arterial stiffness and pulse pressure amplification</article-title>. <source>Hypertension</source>. <year>2003</year>;<volume>41</volume>(<issue>1</issue>):<fpage>183</fpage>&#x02013;<lpage>7</lpage>. Epub 2003/01/04. .<pub-id pub-id-type="pmid">12511550</pub-id></mixed-citation></ref><ref id="pone.0195493.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Kubozono</surname><given-names>T</given-names></name>, <name><surname>Miyata</surname><given-names>M</given-names></name>, <name><surname>Ueyama</surname><given-names>K</given-names></name>, <name><surname>Hamasaki</surname><given-names>S</given-names></name>, <name><surname>Kusano</surname><given-names>K</given-names></name>, <name><surname>Kubozono</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Acute and chronic effects of smoking on arterial stiffness</article-title>. <source>Circulation journal: official journal of the Japanese Circulation Society</source>. <year>2011</year>;<volume>75</volume>(<issue>3</issue>):<fpage>698</fpage>&#x02013;<lpage>702</lpage>. Epub 2010/12/29. .<pub-id pub-id-type="pmid">21187657</pub-id></mixed-citation></ref><ref id="pone.0195493.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Benowitz</surname><given-names>NL</given-names></name>, <name><surname>Jacob</surname><given-names>P</given-names><suffix>3rd</suffix></name>, <name><surname>Jones</surname><given-names>RT</given-names></name>, <name><surname>Rosenberg</surname><given-names>J</given-names></name>. <article-title>Interindividual variability in the metabolism and cardiovascular effects of nicotine in man</article-title>. <source>The Journal of pharmacology and experimental therapeutics</source>. <year>1982</year>;<volume>221</volume>(<issue>2</issue>):<fpage>368</fpage>&#x02013;<lpage>72</lpage>. Epub 1982/05/01. .<pub-id pub-id-type="pmid">7077531</pub-id></mixed-citation></ref><ref id="pone.0195493.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Adamopoulos</surname><given-names>D</given-names></name>, <name><surname>Argacha</surname><given-names>JF</given-names></name>, <name><surname>Gujic</surname><given-names>M</given-names></name>, <name><surname>Preumont</surname><given-names>N</given-names></name>, <name><surname>Degaute</surname><given-names>JP</given-names></name>, <name><surname>van de Borne</surname><given-names>P</given-names></name>. <article-title>Acute effects of nicotine on arterial stiffness and wave reflection in healthy young non-smokers</article-title>. <source>Clinical and experimental pharmacology &#x00026; physiology</source>. <year>2009</year>;<volume>36</volume>(<issue>8</issue>):<fpage>784</fpage>&#x02013;<lpage>9</lpage>. Epub 2009/02/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-1681.2009.05141.x">10.1111/j.1440-1681.2009.05141.x</ext-link></comment> .<pub-id pub-id-type="pmid">19207722</pub-id></mixed-citation></ref><ref id="pone.0195493.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Du</surname><given-names>XJ</given-names></name>, <name><surname>Cox</surname><given-names>HS</given-names></name>, <name><surname>Dart</surname><given-names>AM</given-names></name>, <name><surname>Esler</surname><given-names>MD</given-names></name>. <article-title>Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure</article-title>. <source>Cardiovascular research</source>. <year>1999</year>;<volume>43</volume>(<issue>4</issue>):<fpage>919</fpage>&#x02013;<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0008-6363(99)00139-x">10.1016/s0008-6363(99)00139-x</ext-link></comment> .<pub-id pub-id-type="pmid">10615419</pub-id></mixed-citation></ref><ref id="pone.0195493.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Tisdale</surname><given-names>JE</given-names></name>, <name><surname>Patel</surname><given-names>RV</given-names></name>, <name><surname>Webb</surname><given-names>CR</given-names></name>, <name><surname>Borzak</surname><given-names>S</given-names></name>, <name><surname>Zarowitz</surname><given-names>BJ</given-names></name>. <article-title>Proarrhythmic effects of intravenous vasopressors</article-title>. <source>The Annals of pharmacotherapy</source>. <year>1995</year>;<volume>29</volume>(<issue>3</issue>):<fpage>269</fpage>&#x02013;<lpage>81</lpage>. Epub 1995/03/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/106002809502900309">10.1177/106002809502900309</ext-link></comment> .<pub-id pub-id-type="pmid">7606074</pub-id></mixed-citation></ref><ref id="pone.0195493.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Ikarugi</surname><given-names>H</given-names></name>, <name><surname>Taka</surname><given-names>T</given-names></name>, <name><surname>Nakajima</surname><given-names>S</given-names></name>, <name><surname>Noguchi</surname><given-names>T</given-names></name>, <name><surname>Watanabe</surname><given-names>S</given-names></name>, <name><surname>Sasaki</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans</article-title>. <source>Journal of applied physiology (Bethesda, Md: 1985)</source>. <year>1999</year>;<volume>86</volume>(<issue>1</issue>):<fpage>133</fpage>&#x02013;<lpage>8</lpage>. Epub 1999/01/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/jappl.1999.86.1.133">10.1152/jappl.1999.86.1.133</ext-link></comment> .<pub-id pub-id-type="pmid">9887123</pub-id></mixed-citation></ref><ref id="pone.0195493.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Badimon</surname><given-names>L</given-names></name>, <name><surname>Martinez-Gonzalez</surname><given-names>J</given-names></name>, <name><surname>Royo</surname><given-names>T</given-names></name>, <name><surname>Lassila</surname><given-names>R</given-names></name>, <name><surname>Badimon</surname><given-names>JJ</given-names></name>. <article-title>A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall&#x02014;studies in a porcine model</article-title>. <source>Thrombosis and haemostasis</source>. <year>1999</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1736</fpage>&#x02013;<lpage>42</lpage>. Epub 1999/12/29. .<pub-id pub-id-type="pmid">10613663</pub-id></mixed-citation></ref><ref id="pone.0195493.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Tzivoni</surname><given-names>D</given-names></name>, <name><surname>Keren</surname><given-names>A</given-names></name>, <name><surname>Meyler</surname><given-names>S</given-names></name>, <name><surname>Khoury</surname><given-names>Z</given-names></name>, <name><surname>Lerer</surname><given-names>T</given-names></name>, <name><surname>Brunel</surname><given-names>P</given-names></name>. <article-title>Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking</article-title>. <source>Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy</source>. <year>1998</year>;<volume>12</volume>(<issue>3</issue>):<fpage>239</fpage>&#x02013;<lpage>44</lpage>. .<pub-id pub-id-type="pmid">9784902</pub-id></mixed-citation></ref><ref id="pone.0195493.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Hubbard</surname><given-names>R</given-names></name>, <name><surname>Lewis</surname><given-names>S</given-names></name>, <name><surname>Smith</surname><given-names>C</given-names></name>, <name><surname>Godfrey</surname><given-names>C</given-names></name>, <name><surname>Smeeth</surname><given-names>L</given-names></name>, <name><surname>Farrington</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death</article-title>. <source>Tob Control</source>. <year>2005</year>;<volume>14</volume>(<issue>6</issue>):<fpage>416</fpage>&#x02013;<lpage>21</lpage>. Epub 2005/12/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/tc.2005.011387">10.1136/tc.2005.011387</ext-link></comment> ; PubMed Central PMCID: PMCPMC1748112.<pub-id pub-id-type="pmid">16319366</pub-id></mixed-citation></ref><ref id="pone.0195493.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Idris</surname><given-names>AM</given-names></name>, <name><surname>Ibrahim</surname><given-names>SO</given-names></name>, <name><surname>Vasstrand</surname><given-names>EN</given-names></name>, <name><surname>Johannessen</surname><given-names>AC</given-names></name>, <name><surname>Lillehaug</surname><given-names>JR</given-names></name>, <name><surname>Magnusson</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>The Swedish snus and the Sudanese toombak: are they different?</article-title>
<source>Oral Oncol</source>. <year>1998</year>;<volume>34</volume>(<issue>6</issue>):<fpage>558</fpage>&#x02013;<lpage>66</lpage>. .<pub-id pub-id-type="pmid">9930371</pub-id></mixed-citation></ref><ref id="pone.0195493.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>JA</given-names></name>, <name><surname>Sillett</surname><given-names>RW</given-names></name>, <name><surname>McNicol</surname><given-names>MW</given-names></name>. <article-title>Effect of cigar smoking on carboxyhaemoglobin and plasma nicotine concentrations in primary pipe and cigar smokers and ex-cigarette smokers</article-title>. <source>Br Med J</source>. <year>1977</year>;<volume>2</volume>(<issue>6099</issue>):<fpage>1387</fpage>&#x02013;<lpage>9</lpage>. ; PubMed Central PMCID: PMCPMC1632361.<pub-id pub-id-type="pmid">589225</pub-id></mixed-citation></ref><ref id="pone.0195493.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Digard</surname><given-names>H</given-names></name>, <name><surname>Errington</surname><given-names>G</given-names></name>, <name><surname>Richter</surname><given-names>A</given-names></name>, <name><surname>McAdam</surname><given-names>K</given-names></name>. <article-title>Patterns and behaviors of snus consumption in Sweden</article-title>. <source>Nicotine Tob Res</source>. <year>2009</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1175</fpage>&#x02013;<lpage>81</lpage>. Epub 2009/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ntr/ntp118">10.1093/ntr/ntp118</ext-link></comment> ; PubMed Central PMCID: PMCPMC2746836.<pub-id pub-id-type="pmid">19687306</pub-id></mixed-citation></ref><ref id="pone.0195493.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>McAdam</surname><given-names>KG</given-names></name>, <name><surname>Faizi</surname><given-names>A</given-names></name>, <name><surname>Kimpton</surname><given-names>H</given-names></name>, <name><surname>Porter</surname><given-names>A</given-names></name>, <name><surname>Rodu</surname><given-names>B</given-names></name>. <article-title>Polycyclic aromatic hydrocarbons in US and Swedish smokeless tobacco products</article-title>. <source>Chemistry Central journal</source>. <year>2013</year>;<volume>7</volume>(<issue>1</issue>):<fpage>151</fpage> Epub 2013/09/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1752-153X-7-151">10.1186/1752-153X-7-151</ext-link></comment> ; PubMed Central PMCID: PMCPMC3874832.<pub-id pub-id-type="pmid">24011230</pub-id></mixed-citation></ref><ref id="pone.0195493.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Stepanov</surname><given-names>I</given-names></name>, <name><surname>Jensen</surname><given-names>J</given-names></name>, <name><surname>Hatsukami</surname><given-names>D</given-names></name>, <name><surname>Hecht</surname><given-names>SS</given-names></name>. <article-title>New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels</article-title>. <source>Nicotine Tob Res</source>. <year>2008</year>;<volume>10</volume>(<issue>12</issue>):<fpage>1773</fpage>&#x02013;<lpage>82</lpage>. Epub 2008/11/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14622200802443544">10.1080/14622200802443544</ext-link></comment> ; PubMed Central PMCID: PMCPMC2892835.<pub-id pub-id-type="pmid">19023828</pub-id></mixed-citation></ref><ref id="pone.0195493.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>VanRooij</surname><given-names>JG</given-names></name>, <name><surname>Bodelier-Bade</surname><given-names>MM</given-names></name>, <name><surname>Jongeneelen</surname><given-names>FJ</given-names></name>. <article-title>Estimation of individual dermal and respiratory uptake of polycyclic aromatic hydrocarbons in 12 coke oven workers</article-title>. <source>Br J Ind Med</source>. <year>1993</year>;<volume>50</volume>(<issue>7</issue>):<fpage>623</fpage>&#x02013;<lpage>32</lpage>. ; PubMed Central PMCID: PMCPMC1035498.<pub-id pub-id-type="pmid">8343423</pub-id></mixed-citation></ref><ref id="pone.0195493.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Qiu</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>G</given-names></name>. <article-title>Polycyclic aromatic hydrocarbon (PAH) exposure and oxidative stress for a rural population from the North China Plain</article-title>. <source>Environ Sci Pollut Res Int</source>. <year>2015</year>;<volume>22</volume>(<issue>3</issue>):<fpage>1760</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11356-014-3284-y">10.1007/s11356-014-3284-y</ext-link></comment> .<pub-id pub-id-type="pmid">25015715</pub-id></mixed-citation></ref><ref id="pone.0195493.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>JS</given-names></name>, <name><surname>Beck</surname><given-names>DT</given-names></name>, <name><surname>Gurovich</surname><given-names>AN</given-names></name>, <name><surname>Braith</surname><given-names>RW</given-names></name>. <article-title>The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics</article-title>. <source>Exp Biol Med (Maywood)</source>. <year>2010</year>;<volume>235</volume>(<issue>10</issue>):<fpage>1263</fpage>&#x02013;<lpage>8</lpage>. Epub 2010/08/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1258/ebm.2010.009376">10.1258/ebm.2010.009376</ext-link></comment> ; PubMed Central PMCID: PMCPMC2971534.<pub-id pub-id-type="pmid">20719817</pub-id></mixed-citation></ref><ref id="pone.0195493.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Digard</surname><given-names>H</given-names></name>, <name><surname>Proctor</surname><given-names>C</given-names></name>, <name><surname>Kulasekaran</surname><given-names>A</given-names></name>, <name><surname>Malmqvist</surname><given-names>U</given-names></name>, <name><surname>Richter</surname><given-names>A</given-names></name>. <article-title>Determination of nicotine absorption from multiple tobacco products and nicotine gum</article-title>. <source>Nicotine Tob Res</source>. <year>2013</year>;<volume>15</volume>(<issue>1</issue>):<fpage>255</fpage>&#x02013;<lpage>61</lpage>. Epub 2012/05/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ntr/nts123">10.1093/ntr/nts123</ext-link></comment> ; PubMed Central PMCID: PMCPMC3524070.<pub-id pub-id-type="pmid">22585541</pub-id></mixed-citation></ref><ref id="pone.0195493.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>BL</given-names></name>, <name><surname>Benowitz</surname><given-names>NL</given-names></name>, <name><surname>Jacob</surname><given-names>P</given-names><suffix>3rd</suffix></name>. <article-title>Influence of tobacco abstinence on the disposition kinetics and effects of nicotine</article-title>. <source>Clinical pharmacology and therapeutics</source>. <year>1987</year>;<volume>41</volume>(<issue>4</issue>):<fpage>474</fpage>&#x02013;<lpage>9</lpage>. Epub 1987/04/01. .<pub-id pub-id-type="pmid">3829584</pub-id></mixed-citation></ref><ref id="pone.0195493.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Fattinger</surname><given-names>K</given-names></name>, <name><surname>Verotta</surname><given-names>D</given-names></name>, <name><surname>Benowitz</surname><given-names>NL</given-names></name>. <article-title>Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans</article-title>. <source>The Journal of pharmacology and experimental therapeutics</source>. <year>1997</year>;<volume>281</volume>(<issue>3</issue>):<fpage>1238</fpage>&#x02013;<lpage>46</lpage>. Epub 1997/06/01. .<pub-id pub-id-type="pmid">9190859</pub-id></mixed-citation></ref><ref id="pone.0195493.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Tanino</surname><given-names>Y</given-names></name>, <name><surname>Shite</surname><given-names>J</given-names></name>, <name><surname>Paredes</surname><given-names>OL</given-names></name>, <name><surname>Shinke</surname><given-names>T</given-names></name>, <name><surname>Ogasawara</surname><given-names>D</given-names></name>, <name><surname>Sawada</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Whole body bioimpedance monitoring for outpatient chronic heart failure follow up</article-title>. <source>Circulation journal: official journal of the Japanese Circulation Society</source>. <year>2009</year>;<volume>73</volume>(<issue>6</issue>):<fpage>1074</fpage>&#x02013;<lpage>9</lpage>. .<pub-id pub-id-type="pmid">19372625</pub-id></mixed-citation></ref><ref id="pone.0195493.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Raaijmakers</surname><given-names>E</given-names></name>, <name><surname>Faes</surname><given-names>TJ</given-names></name>, <name><surname>Scholten</surname><given-names>RJ</given-names></name>, <name><surname>Goovaerts</surname><given-names>HG</given-names></name>, <name><surname>Heethaar</surname><given-names>RM</given-names></name>. <article-title>A meta-analysis of three decades of validating thoracic impedance cardiography</article-title>. <source>Critical care medicine</source>. <year>1999</year>;<volume>27</volume>(<issue>6</issue>):<fpage>1203</fpage>&#x02013;<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/00003246-199906000-00053">10.1097/00003246-199906000-00053</ext-link></comment> .<pub-id pub-id-type="pmid">10397230</pub-id></mixed-citation></ref><ref id="pone.0195493.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Sundstrom</surname><given-names>D</given-names></name>, <name><surname>Waldenborg</surname><given-names>M</given-names></name>, <name><surname>Emilsson</surname><given-names>K</given-names></name>. <article-title>Acute effects on the ventricular function in Swedish snuffers: an echocardiographic study</article-title>. <source>Clin Physiol Funct Imaging</source>. <year>2012</year>;<volume>32</volume>(<issue>2</issue>):<fpage>106</fpage>&#x02013;<lpage>13</lpage>. Epub 2012/02/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1475-097X.2011.01062.x">10.1111/j.1475-097X.2011.01062.x</ext-link></comment> .<pub-id pub-id-type="pmid">22296630</pub-id></mixed-citation></ref><ref id="pone.0195493.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Alam</surname><given-names>M</given-names></name>, <name><surname>Samad</surname><given-names>BA</given-names></name>, <name><surname>Wardell</surname><given-names>J</given-names></name>, <name><surname>Andersson</surname><given-names>E</given-names></name>, <name><surname>Hoglund</surname><given-names>C</given-names></name>, <name><surname>Nordlander</surname><given-names>R</given-names></name>. <article-title>Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2002</year>;<volume>15</volume>(<issue>10</issue> Pt 2):<fpage>1232</fpage>&#x02013;<lpage>7</lpage>. .<pub-id pub-id-type="pmid">12411910</pub-id></mixed-citation></ref><ref id="pone.0195493.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Janner</surname><given-names>JH</given-names></name>, <name><surname>Godtfredsen</surname><given-names>NS</given-names></name>, <name><surname>Ladelund</surname><given-names>S</given-names></name>, <name><surname>Vestbo</surname><given-names>J</given-names></name>, <name><surname>Prescott</surname><given-names>E</given-names></name>. <article-title>Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device</article-title>. <source>Am J Hypertens</source>. <year>2010</year>;<volume>23</volume>(<issue>2</issue>):<fpage>180</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ajh.2009.234">10.1038/ajh.2009.234</ext-link></comment> .<pub-id pub-id-type="pmid">19959999</pub-id></mixed-citation></ref><ref id="pone.0195493.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Koskinen</surname><given-names>J</given-names></name>, <name><surname>Magnussen</surname><given-names>CG</given-names></name>, <name><surname>Viikari</surname><given-names>JS</given-names></name>, <name><surname>Kahonen</surname><given-names>M</given-names></name>, <name><surname>Laitinen</surname><given-names>T</given-names></name>, <name><surname>Hutri-Kahonen</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6-year follow-up. The cardiovascular risk in Young Finns study</article-title>. <source>Atherosclerosis</source>. <year>2012</year>;<volume>224</volume>(<issue>2</issue>):<fpage>474</fpage>&#x02013;<lpage>9</lpage>. Epub 2012/05/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.atherosclerosis.2012.04.004">10.1016/j.atherosclerosis.2012.04.004</ext-link></comment> .<pub-id pub-id-type="pmid">22624989</pub-id></mixed-citation></ref><ref id="pone.0195493.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Hayward</surname><given-names>CS</given-names></name>, <name><surname>Kelly</surname><given-names>RP</given-names></name>. <article-title>Gender-related differences in the central arterial pressure waveform</article-title>. <source>J Am Coll Cardiol</source>. <year>1997</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1863</fpage>&#x02013;<lpage>71</lpage>. Epub 1997/12/31. .<pub-id pub-id-type="pmid">9385920</pub-id></mixed-citation></ref><ref id="pone.0195493.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Gatzka</surname><given-names>CD</given-names></name>, <name><surname>Kingwell</surname><given-names>BA</given-names></name>, <name><surname>Cameron</surname><given-names>JD</given-names></name>, <name><surname>Berry</surname><given-names>KL</given-names></name>, <name><surname>Liang</surname><given-names>YL</given-names></name>, <name><surname>Dewar</surname><given-names>EM</given-names></name>, <etal>et al</etal>
<article-title>Gender differences in the timing of arterial wave reflection beyond differences in body height</article-title>. <source>J Hypertens</source>. <year>2001</year>;<volume>19</volume>(<issue>12</issue>):<fpage>2197</fpage>&#x02013;<lpage>203</lpage>. .<pub-id pub-id-type="pmid">11725164</pub-id></mixed-citation></ref><ref id="pone.0195493.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>GF</given-names></name>, <name><surname>Parise</surname><given-names>H</given-names></name>, <name><surname>Benjamin</surname><given-names>EJ</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Keyes</surname><given-names>MJ</given-names></name>, <name><surname>Vita</surname><given-names>JA</given-names></name>, <etal>et al</etal>
<article-title>Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study</article-title>. <source>Hypertension</source>. <year>2004</year>;<volume>43</volume>(<issue>6</issue>):<fpage>1239</fpage>&#x02013;<lpage>45</lpage>. Epub 2004/05/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.HYP.0000128420.01881.aa">10.1161/01.HYP.0000128420.01881.aa</ext-link></comment> .<pub-id pub-id-type="pmid">15123572</pub-id></mixed-citation></ref><ref id="pone.0195493.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Russo</surname><given-names>C</given-names></name>, <name><surname>Jin</surname><given-names>Z</given-names></name>, <name><surname>Palmieri</surname><given-names>V</given-names></name>, <name><surname>Homma</surname><given-names>S</given-names></name>, <name><surname>Rundek</surname><given-names>T</given-names></name>, <name><surname>Elkind</surname><given-names>MS</given-names></name>, <etal>et al</etal>
<article-title>Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function</article-title>. <source>Hypertension</source>. <year>2012</year>;<volume>60</volume>(<issue>2</issue>):<fpage>362</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/HYPERTENSIONAHA.112.191148">10.1161/HYPERTENSIONAHA.112.191148</ext-link></comment> ; PubMed Central PMCID: PMCPMC3402954.<pub-id pub-id-type="pmid">22753223</pub-id></mixed-citation></ref><ref id="pone.0195493.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>GF</given-names></name>, <name><surname>Gudnason</surname><given-names>V</given-names></name>, <name><surname>Launer</surname><given-names>LJ</given-names></name>, <name><surname>Aspelund</surname><given-names>T</given-names></name>, <name><surname>Harris</surname><given-names>TB</given-names></name>. <article-title>Hemodynamics of increased pulse pressure in older women in the community-based Age, Gene/Environment Susceptibility-Reykjavik Study</article-title>. <source>Hypertension</source>. <year>2008</year>;<volume>51</volume>(<issue>4</issue>):<fpage>1123</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/HYPERTENSIONAHA.107.108175">10.1161/HYPERTENSIONAHA.107.108175</ext-link></comment> .<pub-id pub-id-type="pmid">18259005</pub-id></mixed-citation></ref></ref-list></back></article>